Squarepoint Ops LLC

Position in STOK — Stoke Therapeutics, Inc.

CIK 1642575 NEW YORK, NY

Position in STOK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$959,023

+$692,775 QoQ

Shares Held

29,310

+24.9% QoQ

Ownership

0.045%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#96

of 198 holders

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,234,483,670 across 254 Biotechnology names. STOK ranks #111 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	198,567	$123,814,467
2	BBIO	BridgeBio Pharma, Inc.	1,191,732	$88,760,199
3	ALNY	Alnylam Pharmaceuticals, Inc.	233,999	$70,440,718
4	INSM	INSMED Inc	616,464	$65,727,391
5	ARGX	Argenx SE	58,400	$54,181,768
6	RYTM	Rhythm Pharmaceuticals, Inc.	422,921	$46,956,918
7	APGE	Apogee Therapeutics, Inc.	290,713	$38,586,336
8	AXSM	Axsome Therapeutics, Inc.	154,605	$37,842,665

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$959,023	29,310	+24.9%	Shares	Defined	2026-08-14
2025-06-30	$266,248	23,458	-80.5%	Shares	Defined	2025-08-27
2024-12-31	$1,326,269	120,242	+6.7%	Shares	Defined	2025-02-14
2024-09-30	$1,384,677	112,667	+649.0%	Shares	Defined	2024-11-14
2024-06-30	$203,217	15,042	-70.6%	Shares	Defined	2024-08-14
2024-03-31	$689,809	51,097	+167.6%	Shares	Defined	2024-05-15
2023-12-31	$100,444	19,096	+25.5%	Shares	Defined	2024-02-14
2023-09-30	$59,927	15,210	-14.8%	Shares	Defined	2023-11-14
2023-03-31	$148,698	17,851	+174.8%	Shares	Defined	2023-05-15
2021-06-30	$218,621	6,495	-39.4%	Shares	Defined	2021-08-16
2021-03-31	$416,054	10,712	-1.2%	Shares	Defined	2021-05-17
2020-09-30	$362,931	10,837	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.